A medication once used only to treat breast cancer, is showing great promise for preventing it in high risk women.

Hormone therapy (also called hormonal therapy or endocrine therapy) slows or stops the growth of hormone-sensitive tumors by blocking the body’s ability to produce hormones or by interfering with the ...

October is Breast Cancer Awareness Month and the Lynn Sage Foundation has become synonymous with research on the disease.

Sometimes oncologists will try a different AI; some often work well for one particular woman but not for another. Some ...

Switching to an AI following 2–3 years of initial adjuvant tamoxifen is an effective option for patients unable to begin treatment with an AI. This article evaluates the most up-to-date results ...

Women taking a new breast cancer drug are living longer than those taking Tamoxifen - the current 'gold standard' treatment. Doctors predict the new drug, Arimidex, will improve long-term survival ...

Thousands decked out in pink came out to show their support in the fight to end breast cancer at Barton Creek Square at the ...

In an interview with Targeted Oncology, Erika Hamilton, MD, discussed emerging endocrine therapies that are advancing breast ...

Program for Cancer and Cell Biology, Department of Human Anatomy, Histology and Embryology, School of Basic Medical Sciences; Peking University International Cancer Institute; and State Key Laboratory ...

JAMESTOWN — Oct. 1 marked a remission milestone for Bonnie Schmitz, the Gift Shoppe coordinator at Jamestown Regional Medical ...

In a recent webinar, Dalia Rosano Imperial College London) discussed breast cancer and epigenetic combination therapies.

Dense breasts are not the only factor increasing the risk for a breast cancer diagnosis. Family history matters, especially ...